UPDATED UNDERSTANDING OF THE MOLECULAR TARGETS OF RADIOIODINE IN DIFFERENTIATED THYROID CANCER

被引:1
作者
Zhang, Y. [1 ]
Zou, W. [2 ]
Zhu, X. [1 ]
Jiang, L. [1 ]
Gui, C. [1 ]
Fan, Q. [1 ]
Tu, Y. [3 ]
Chen, J. [1 ]
机构
[1] Hubei Canc Hosp, Dept Head & Neck Surg, Wuhan 430079, Peoples R China
[2] First Peoples Hosp Yichang, Dept Gen Surg 2, Yichang, Hubei, Peoples R China
[3] Liuzhou Tradit Chinese Med Hosp, Dept Otolaryngol & Head & Neck Surg, Liuzhou, Guangxi, Peoples R China
关键词
Radioactive iodine (RAI); thyroid cancer; iodine transport system; I-; uptake; RADIOACTIVE IODINE THERAPY; SODIUM/IODIDE SYMPORTER; NECK RECURRENCE; CARCINOMA; OUTCOMES; PENDRIN; CELLS; EXPRESSION; EFFLUX; NIS;
D O I
10.4183/aeb.2022.86
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Radioactive iodine (RAI) therapy is a mainstay adjuvant treatment for thyroid cancer. Administration of RAI therapy after total or near-total thyroidectomy has shown a survival advantage in numerous properly selected patients. However, the role of RAI therapy after reoperation for persistent or recurrent differentiated thyroid carcinomas (DTCs) is unclear. One reason may be the possible downregulation of the I- transport system after primary surgery. RAI is transported by the sodium iodide symporter (NIS), PENDRIN, anoctamin 1 (ANO1) and cystic fibrosis transmembrane conductance regulator (CFTR) and emits beta particles that destroy follicular cells. The identification of pathways of iodide (I-) transport has allowed use of the transport system to render tumours susceptible to RAI treatment via gene therapy. This review focuses on the effect of RAI therapy in follicular cell-derived thyroid cancers and offers potential novel targets that enable improved radioiodine uptake and thus an improved prognosis of thyroid cancer.
引用
收藏
页码:86 / 92
页数:7
相关论文
共 50 条
[21]   Radioiodine therapy in the different stages of differentiated thyroid cancer [J].
Valerio, Laura ;
Maino, Fabio ;
Castagna, Maria Grazia ;
Pacini, Furio .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 37 (01)
[22]   The Evolving Use of Radioiodine Therapy in Differentiated Thyroid Cancer [J].
Mayson, Sarah E. ;
Yoo, Don C. ;
Gopalakrishnan, Geetha .
ONCOLOGY, 2015, 88 (04) :247-256
[23]   Advanced Radioiodine-refractory differentiated Thyroid Cancer [J].
Spitzweg, Christine ;
Auernhammer, Christoph J. ;
Geisler, Julia ;
Boeck, Stefan ;
Heinemann, Volker ;
Bartenstein, Peter ;
Goeke, Burkhard .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (03) :168-171
[24]   Controversies in the Radioiodine Treatment of Patients With Differentiated Thyroid Cancer [J].
Buscombe, John .
SEMINARS IN NUCLEAR MEDICINE, 2023, 53 (04) :475-480
[25]   Assessment of radioiodine clearance in patients with differentiated thyroid cancer [J].
Tabei, Faraj ;
Asli, Isa Neshandar ;
Azizmohammadi, Zahra ;
Javadi, Hamid ;
Assadi, Majid .
RADIATION PROTECTION DOSIMETRY, 2012, 152 (04) :323-327
[26]   Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients [J].
Castagna, M. G. ;
Cantara, S. ;
Pacini, F. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2016, 39 (10) :1087-1094
[27]   Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients [J].
M. G. Castagna ;
S. Cantara ;
F. Pacini .
Journal of Endocrinological Investigation, 2016, 39 :1087-1094
[28]   THE ASSOCIATION BETWEEN LYMPH NODE METASTASIS AND MOLECULAR MARKERS IN DIFFERENTIATED THYROID CANCER [J].
Aydogan, B., I ;
Ersoz, C. C. ;
Sak, S. D. ;
Gullu, S. .
ACTA ENDOCRINOLOGICA-BUCHAREST, 2018, 14 (01) :55-65
[29]   Pictorial Review of False-Positive Results on Radioiodine Scintigrams of Patients with Differentiated Thyroid Cancer [J].
Chudgar, Amy V. ;
Shah, Jagruti C. .
RADIOGRAPHICS, 2017, 37 (01) :298-315
[30]   Survival Predictors of Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib in Real Life [J].
Marotta, Vincenzo ;
Rocco, Domenico ;
Crocco, Anna ;
Deiana, Maria Grazia ;
Martinelli, Ruggero ;
Di Gennaro, Francesca ;
Valeriani, Mariafelicia ;
Valvano, Luca ;
Caleo, Alessia ;
Pezzullo, Luciano ;
Faggiano, Antongiulio ;
Vitale, Mario ;
Monti, Salvatore .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (10) :2541-2552